A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy - Related Studies

Home

A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy

This study has been completed.

Study NCT00074854. Last updated on November 8, 2006. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lung Neoplasms

2	More general conditions related to this trial
		Lung Diseases
		Neoplasms
		Neoplasms by Site
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

3	Interventions listed in this trial
		CP-547,632

4	Sponsors listed in this trial
		Pfizer